Dr Lal PathLabs completes the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL) in Ghana. The purchase is carried out through its wholly owned Dubai subsidiary, Dr Lal PathLabs FZCO (DLPL Dubai), and results in SHL becoming a step-down subsidiary of Dr Lal PathLabs.
The company says the acquisition is completed in line with the relevant agreement and applicable provisions in Ghana. The news follows earlier intimation on July 24, 2026, when the board approved the acquisition. One filing referenced by the outlets also cites prior regulatory intimation related to SEBI circulars dated July 13, 2023.
Both outlets describe the transaction in similar terms, focusing on completion status, the 80% ownership stake, and the resulting subsidiary classification. Neither source provides additional financial terms, governance arrangements, or operational changes at SHL beyond the ownership and compliance details based on company disclosures.
